Cooper Companies | COO - Operating Expenses


Cooper Companies reported $924.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Bausch Health Companies USD 2.08B 113M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dentsply International USD 1.48B 653M Sep/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Novartis USD 9.77B 401M Sep/2025
ResMed USD 925.21M 51.98M Dec/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.82B 3.22B Sep/2025
Utah Medical Products USD 6.25M 80K Sep/2024
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025